Cargando…
Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143906/ https://www.ncbi.nlm.nih.gov/pubmed/34044036 http://dx.doi.org/10.1016/j.jinf.2021.05.017 |
| _version_ | 1783696849960435712 |
|---|---|
| author | Yamamoto, Shohei Tanaka, Akihito Oshiro, Yusuke Ishii, Masamichi Ishiwari, Hironori Konishi, Maki Matsuda, Kouki Ozeki, Mitsuru Miyo, Kengo Maeda, Kenji Mizoue, Tetsuya Sugiura, Wataru Mitsuya, Hiroaki Sugiyama, Haruhito Ohmagari, Norio |
| author_facet | Yamamoto, Shohei Tanaka, Akihito Oshiro, Yusuke Ishii, Masamichi Ishiwari, Hironori Konishi, Maki Matsuda, Kouki Ozeki, Mitsuru Miyo, Kengo Maeda, Kenji Mizoue, Tetsuya Sugiura, Wataru Mitsuya, Hiroaki Sugiyama, Haruhito Ohmagari, Norio |
| author_sort | Yamamoto, Shohei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8143906 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81439062021-05-25 Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan Yamamoto, Shohei Tanaka, Akihito Oshiro, Yusuke Ishii, Masamichi Ishiwari, Hironori Konishi, Maki Matsuda, Kouki Ozeki, Mitsuru Miyo, Kengo Maeda, Kenji Mizoue, Tetsuya Sugiura, Wataru Mitsuya, Hiroaki Sugiyama, Haruhito Ohmagari, Norio J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-08 2021-05-25 /pmc/articles/PMC8143906/ /pubmed/34044036 http://dx.doi.org/10.1016/j.jinf.2021.05.017 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Yamamoto, Shohei Tanaka, Akihito Oshiro, Yusuke Ishii, Masamichi Ishiwari, Hironori Konishi, Maki Matsuda, Kouki Ozeki, Mitsuru Miyo, Kengo Maeda, Kenji Mizoue, Tetsuya Sugiura, Wataru Mitsuya, Hiroaki Sugiyama, Haruhito Ohmagari, Norio Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan |
| title | Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan |
| title_full | Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan |
| title_fullStr | Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan |
| title_full_unstemmed | Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan |
| title_short | Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan |
| title_sort | seroprevalence of sars-cov-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of japan |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143906/ https://www.ncbi.nlm.nih.gov/pubmed/34044036 http://dx.doi.org/10.1016/j.jinf.2021.05.017 |
| work_keys_str_mv | AT yamamotoshohei seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan AT tanakaakihito seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan AT oshiroyusuke seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan AT ishiimasamichi seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan AT ishiwarihironori seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan AT konishimaki seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan AT matsudakouki seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan AT ozekimitsuru seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan AT miyokengo seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan AT maedakenji seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan AT mizouetetsuya seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan AT sugiurawataru seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan AT mitsuyahiroaki seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan AT sugiyamaharuhito seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan AT ohmagarinorio seroprevalenceofsarscov2antibodiesinanationalhospitalandaffiliatedfacilityafterthesecondepidemicwaveofjapan |